| Gavin Stormont, | |
|
1421 Premier Dr, Mankato, MN 56001-6076 | |
| (507) 625-1811 | |
| Not Available |
| Full Name | Gavin Stormont |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 7 Years |
| Location | 1421 Premier Dr, Mankato, Minnesota |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639690589 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 8112 (Nebraska) | Secondary |
| 208800000X | Urology | 71498 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| River's Edge Hospital & Clinic | St peter, MN | Hospital |
| New Ulm Medical Center | New ulm, MN | Hospital |
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mankato Clinic Ltd | 5597677955 | 201 |
News Archive
Molecular Partners AG, a pioneer in the development of DARPins as next generation protein therapeutics, has announced the closing of its Series B equity investment round securing CHF 46 million (€ 30 million, $ 45 million).
A new review paper by the researchers from Spain, published in the journal Cytokine & Growth Factor Reviews, demonstrates how changes in the levels of cytokines and other biomolecules are associated with the presence and more serious prognosis of coronavirus disease (COVID-19).
The shortened daylight of a Maine winter may make for long, dark nights - but it has shone a light on a novel experimental approach to fighting inflammatory breast cancer (IBC), an especially deadly form of breast cancer.
Researchers report that a new lipid nanoparticle mRNA coronavirus disease 2019 (COVID-19) vaccine candidate protected 70% of mice expressing the human angiotensin-converting enzyme 2 (ACE2), while all the non-vaccinated mice died.
› Verified 1 days ago
| Entity Name | Mankato Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629044029 PECOS PAC ID: 5597677955 Enrollment ID: O20031104000231 |
News Archive
Molecular Partners AG, a pioneer in the development of DARPins as next generation protein therapeutics, has announced the closing of its Series B equity investment round securing CHF 46 million (€ 30 million, $ 45 million).
A new review paper by the researchers from Spain, published in the journal Cytokine & Growth Factor Reviews, demonstrates how changes in the levels of cytokines and other biomolecules are associated with the presence and more serious prognosis of coronavirus disease (COVID-19).
The shortened daylight of a Maine winter may make for long, dark nights - but it has shone a light on a novel experimental approach to fighting inflammatory breast cancer (IBC), an especially deadly form of breast cancer.
Researchers report that a new lipid nanoparticle mRNA coronavirus disease 2019 (COVID-19) vaccine candidate protected 70% of mice expressing the human angiotensin-converting enzyme 2 (ACE2), while all the non-vaccinated mice died.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gavin Stormont, 1421 Premier Dr, Mankato, MN 56001-6076 Ph: () - | Gavin Stormont, 1421 Premier Dr, Mankato, MN 56001-6076 Ph: (507) 625-1811 |
News Archive
Molecular Partners AG, a pioneer in the development of DARPins as next generation protein therapeutics, has announced the closing of its Series B equity investment round securing CHF 46 million (€ 30 million, $ 45 million).
A new review paper by the researchers from Spain, published in the journal Cytokine & Growth Factor Reviews, demonstrates how changes in the levels of cytokines and other biomolecules are associated with the presence and more serious prognosis of coronavirus disease (COVID-19).
The shortened daylight of a Maine winter may make for long, dark nights - but it has shone a light on a novel experimental approach to fighting inflammatory breast cancer (IBC), an especially deadly form of breast cancer.
Researchers report that a new lipid nanoparticle mRNA coronavirus disease 2019 (COVID-19) vaccine candidate protected 70% of mice expressing the human angiotensin-converting enzyme 2 (ACE2), while all the non-vaccinated mice died.
› Verified 1 days ago
Gary S Goldberg, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1421 Premiere Dr, Mankato Clinic@ Wickersham Campus, Mankato, MN 56001 Phone: 507-625-1811 | |
Dr. Laurence T O'connor, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Michael C James, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1421 Premiere Dr, Mankato Clinic At Wickersham Campus, Mankato, MN 56001 Phone: 507-625-1811 | |
Joe Y Lee, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
David Yuzhi Yang, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Dr. Derek Gearman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
Spencer Andrew Bershow, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 |